Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry

Clinica Chimica Acta

Volumn 440, Issue , 2015, Pages 31-35

  Villanelli, Fabio ^a   Giocaliere, Elisa ^a   Malvagia, Sabrina ^a   Rosati, Anna ^a   Forni, Giulia ^a   Funghini, Silvia ^a   Shokry, Engy ^c   Ombrone, Daniela ^a   Della Bona, Maria Luisa ^a   Guerrini, Renzo ^a,b   la Marca, Giancarlo ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Future University in Egypt   (Egypt)

Author keywords

Anticonvulsant drug; Dried blood spot; Epilepsy; Phenytoin; Tandem mass spectrometry; Therapeutic drug monitoring

Indexed keywords

PHENYTOIN;

ACCURACY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DRIED BLOOD SPOT TESTING; DRUG BLOOD LEVEL; DRUG DETERMINATION; EXTRACTION; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RELIABILITY; SENSITIVITY ANALYSIS; TEMPERATURE; BLOOD; CALIBRATION; DRUG MONITORING; DRUG STABILITY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY;

CALIBRATION; CHROMATOGRAPHY, LIQUID; DRIED BLOOD SPOT TESTING; DRUG MONITORING; DRUG STABILITY; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; PHENYTOIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL-TO-NOISE RATIO; TANDEM MASS SPECTROMETRY;

EID: 84913538023     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.11.007     Document Type: Article

References (25)

1. Rogawski M.A., Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
2. Akula R., Hasan S., Pipalla R., Ferguson C. Noncompliance leading to drug accumulation resulting in Phenytoin toxicity. J Natl Med Assoc 2003, 95:1201-1203.
3. Sivathanu S., Sampath S., David H.S., Rajavelu K.K. Myristicin and Phenytoin toxicity in an infant. BMJ Case Rep Jun 5 2014, 10.1136/bcr-2013-203000.
4. Richens A. Clinical pharmacokinetics of phenytoin. Clin Pharmacokinet 1979, 4:153-169.
5. Srikanth C.H., Chaira T., Sampathi S., VBS, Bambal R.B. Correlation of in vitro and in vivo plasma protein binding using ultracentrifugation and UPLC-tandem mass spectrometry. Analyst 2013, 138:6106-6116.
6. Garg U., Peat J., Frazee C., Nguyen T., Ferguson A.M. A simple isotope dilution electrospray ionization tandem mass spectrometry method for the determination of free phenytoin. Ther Drug Monit 2013, 35:831-835.
7. Nation R.L., Evans A.M., Milne R.W. Pharmacokinetic drug interactions with phenytoin (Part I). Clin Pharmacokinet 1990, 18:37-60.
8. Rall T.W., Schleifer L.S. Drugs effective in the therapy of the epilepsies. The pharmacological basis of therapeutics 1985, 446-472. MacMillan Publishing Co., New York. 7th ed. L.S. Goodman, A.G. Gilman (Eds.).
9. Heine R.T., van Maarseveen E.M., van der Westerlaken M.M., Braun K.P., Koudijs S.M., Berg M.J., et al. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children. J Child Neurol 2013, 29:803-810.
10. Bardin S., Ottinger J.C., Breau A.P., O'Shea T.J. Determination of free levels of phenytoin in human plasma by liquid chromatography: tandem mass spectrometry. J Pharm Biomed Anal 2000, 23:573-579.
11. Zhang Y., Mehrotra N., Budha N.R., Christensen M.L., Meibohm B. A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens. Clin Chim Acta 2008, 398:105-112.
12. Sørensen L.K. Determination of acidic and neutral therapeutic drugs in human blood by liquid chromatography-electrospray tandem mass spectrometry. Forensic Sci Int 2011, 206:119-126.
13. Matar K.M., Nicholls P.J., Tekle A., Bawazir S.A., Al-Hassan M.I. Liquid chromatographic determination of six antiepileptic drugs and two metabolites in microsamples of human plasma. Ther Drug Monit 1999, 21:559-566.
14. Li W., Tse F.L. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr 2010, 24:49-65.
15. Coombes E.J., Gamlen T.R., Batstone G.F., Leigh P.N. A phenytoin assay using dried blood spot samples suitable for domiciliary therapeutic drug monitoring. Ann Clin Biochem 1984, 21:519-522.
16. Lee Y.W. Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin A and tacrolimus levels in whole blood. Exp Ther Med 2013, 6:1535-1539.
17. Abdel-Hamid M.E. Comparative LC-MS and HPLC analyses of selected antiepileptics and beta-blocking drugs. Farmaco 2000, 55:136-145.
18. Hirata K., Saruwatari J., Enoki Y., Iwata K., Urata Y., Aizawa K., et al. Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM. Ther Drug Monit 2014, 36:553-555.
19. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonized tripartite guideline: validation of analytical procedures: text and methodology Q2(R1) 2005.
20. Van Eeckhaut A., Lanckmans K., Sarre S., Smolders I., Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:2198-2207.
21. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal Chem 1998, 70:882-889.
22. Annesley T. Ion suppression in mass spectrometry. Clin Chem 2003, 49:1041-1044.
23. Vu D.H., Koster R.A., Alffenaar J.W., Brouwers J.R., Uges D.R. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879:1063-1070.
24. Denniff P., Spooner N. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates. Bioanalysis 2010, 2:1817-1822.
25. la Marca G., Malvagia S., Filippi L., Innocenti M., Rosati A., Falchi M., et al. Rapid assay of rufinamide in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal 2011, 54:192-197.